$MNOV Company News Thursday’s top gaining and

New Post Public Reply Private Reply Replies (0) Message Board

Sep 16, 2014 at 10:37 AM

$MNOV Company News

Thursday’s top gaining and declining stocks 3:24 p.m. May 24, 2012 - MarketWatch
MediciNova dives on asthma study results 12:46 p.m. May 24, 2012 - Val Brickates Kennedy
H-P climbs, NetApp tumbles in after-hours trade 6:49 p.m. May 23, 2012 - Carla Mozee
MediciNova study doesn't yield significant results 5:10 p.m. May 23, 2012 - MarketWatch.com
Drug stocks move higher in late trading 3:26 p.m. March 24, 2011 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:37 p.m. Aug. 21, 2009 - MarketWatch
The Gap, J.M. Smucker, Ann Taylor in view 8:33 a.m. Aug. 21, 2009 - MarketWatch
MediciNova to acquire Avigen for $1.24 a share 6:17 a.m. Aug. 21, 2009 - William L. Watts
MediciNova to buy Avigen for $1.24/share 6:03 a.m. Aug. 21, 2009 - Steve Goldstein
Avigen holders would get net cash value plus $3M 6:13 a.m. June 25, 2009 - Simon Kennedy
MediciNova, Avigen agree terms of proposed deal 6:11 a.m. June 25, 2009 - Simon Kennedy
MediciNova reaches tentative deal to buy Avigen 6:10 a.m. June 25, 2009 - Steve Goldstein
MediciNova proposes to acquire Avigen 7:10 a.m. Dec. 23, 2008 - Aude Lagorce
MediciNova makes offer for Avigen 7:07 a.m. Dec. 23, 2008 - Aude Lagorce
MediciNova reports progress in asthma-drug Phase II trial 6:25 a.m. Sept. 9, 2008 - Robert Daniel
NediciNova reports positive preliminary Phase II results 6:09 a.m. Sept. 9, 2008 - Simon Kennedy
MediciNova withdraws plan for secondary stock offering 7:32 a.m. Nov. 8, 2007 - Mike Maynard
MediciNova pulls public offering of 6M shares 7:22 a.m. Nov. 8, 2007 - Aude Lagorce
MediciNova to focus on 2 drugs, to stop asthma drug trial 6:15 a.m. June 26, 2007 - Sarah Turner
MediciNova to focus on MN-221, MN-166 6:02 a.m. June 26, 2007 - Steve Goldstein

MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog 5:00 p.m. Aug. 28, 2014 - Zacks.com
MediciNova to start ALS trial 11:52 a.m. Aug. 26, 2014 - Seeking Alpha
3 Stocks Pushing The Drugs Industry Lower 4:02 p.m. Aug. 5, 2014 - TheStreet.com
3 Drugs Stocks Pushing The Industry Higher 4:02 p.m. July 30, 2014 - TheStreet.com
10-Q: MEDICINOVA INC 5:12 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
MediciNova: Gestation Is Slow And Uncomfortable - Birth Is Sudden And Unexpected 5:47 p.m. Feb. 25, 2014 - Seeking Alpha
MediciNova rallies on NASH study hopes 9:36 a.m. Jan. 14, 2014 - Seeking Alpha
MediciNova (MNOV) Jumps: Stock Adds 22.2% in Session - Tale of the Tape 9:51 a.m. Dec. 13, 2013 - Zacks.com
10-Q: MEDICINOVA INC 5:14 p.m. Aug. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
MediciNova Presents MN-166 Data - Analyst Blog 6:15 p.m. June 19, 2013 - Zacks.com
Stock Market Today: Big Winners & Losers for Wednesday 4:06 p.m. May 1, 2013 - 247WallSt.com
Biotech Movers: Affymax Crashes on Recall 3:40 a.m. March 4, 2013 - InvestorPlace.com
Secretive Dilution And A Possible Equity Financing From MediciNova 2:49 p.m. Feb. 27, 2013 - Seeking Alpha
4 Healthcare Stock Stories to Heal the Tuesday Blues 6:54 p.m. Feb. 26, 2013 - Wall St. Cheat Sheet
Positive Data on MediciNova's MN-221 - Analyst Blog 5:00 p.m. Aug. 24, 2012 - Zacks.com
3 Reasons This Speculative Bio-Pharma Is A Winner 5:22 p.m. Aug. 10, 2012 - Seeking Alpha
Must Know Stock Upgrades and Downgrades Today 2:51 p.m. May 24, 2012 - Wall St. Cheat Sheet
Signet Jewelers, MediciNova: Biggest Price Decliners (SIG, MNOV) 12:49 p.m. May 24, 2012 - The Wall Street Journal Interactive Edition
End Of Week Bio-Pharma Catalyst Trade And Watch List 7:55 a.m. May 4, 2012 - Seeking Alpha
Health Care Sector Wrap 4:48 p.m. May 3, 2012 - FOXBusiness

MediciNova Announces New NIDA Grant for MN-166 (ibudilast) in Opioid Dependence 7:01 p.m. Sept. 7, 2014 - GlobeNewswire
MediciNova to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF) 7:01 p.m. Sept. 1, 2014 - GlobeNewswire
MediciNova to Initiate Clinical Trial of MN-166 (ibudilast) in ALS 7:01 p.m. Aug. 25, 2014 - GlobeNewswire
MediciNova Announces Positive Interim Results of Phase 2a Study of MN-166 (ibudilast) in Opioid Dependence 7:00 p.m. Aug. 18, 2014 - GlobeNewswire
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Nonalcoholic Fatty Liver Disease 7:07 p.m. Aug. 11, 2014 - GlobeNewswire
Spasticity Global Clinical Trials Review, H2, 2014 4:42 p.m. Aug. 11, 2014 - PR Newswire - PRF
MediciNova Announces Positive Results of MN-001 in Advanced NASH Mouse Model; MediciNova Requests a Meeting With FDA 7:31 a.m. Aug. 5, 2014 - GlobeNewswire
MediciNova to Present Data on MN-001 for the Treatment of NASH (Nonalcoholic Steatohepatitis) During the JDDW 2014 (Japan Digestive Disease Week 2014) 7:00 p.m. July 7, 2014 - GlobeNewswire
MediciNova Announces Positive Results in Study of MN-001 in Mouse Model of Pulmonary Fibrosis 7:00 p.m. June 11, 2014 - GlobeNewswire
MediciNova Announces Management Appointment 7:01 p.m. April 8, 2014 - GlobeNewswire
MediciNova Appoints Yoshio Ishizaka to its Board of Directors 7:01 p.m. April 8, 2014 - GlobeNewswire
Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides 11:01 a.m. April 8, 2014 - ACCESSWIRE
MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S. 9:00 a.m. Jan. 14, 2014 - GlobeNewswire
MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome 7:00 p.m. Nov. 11, 2013 - GlobeNewswire
MediciNova Reports Third Quarter 2013 Results 7:30 p.m. Nov. 7, 2013 - GlobeNewswire
MediciNova Appoints Yutaka Kobayashi to Its Board of Directors 5:00 p.m. Oct. 16, 2013 - GlobeNewswire
MediciNova Appoints Geoffrey O'Brien as Vice President 4:30 p.m. Oct. 16, 2013 - GlobeNewswire
MediciNova Receives Notice of Allowance for New Patent Covering MN-029 (denibulin) di-hydrochloride 7:00 p.m. Oct. 6, 2013 - GlobeNewswire
National Institute on Alcohol Abuse and Alcoholism Funds New UCLA Clinical Trial of MediciNova's MN-166 in Treating Alcoholism 7:00 p.m. Aug. 25, 2013 - GlobeNewswire
MediciNova Reports Second Quarter 2013 Results 5:30 p.m. Aug. 8, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Woodpack Global Unveils Crate Design System: A New Era Begins

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Unpacking RAGEism: Power Dynamics in U.S. Policies

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

GBI Bio's New CEO Jesse McCool to Propel Growth

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...